{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:31:04Z","timestamp":1787020264930,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment","award":["(No. 2016YNZL04)"],"award-info":[{"award-number":["(No. 2016YNZL04)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12886-018-0772-8","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T08:19:18Z","timestamp":1524471558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Characterization, treatment and prognosis of retinoblastoma with central nervous system metastasis"],"prefix":"10.1186","volume":"18","author":[{"given":"Huimin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6397-4553","authenticated-orcid":false,"given":"Dongsheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"772_CR1","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1136\/bjo.2008.150292","volume":"93","author":"T Kivel\u00e4","year":"2009","unstructured":"Kivel\u00e4 T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129\u201331.","journal-title":"Br J Ophthalmol"},{"key":"772_CR2","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/00006982-200412000-00002","volume":"24","author":"DH Abramson","year":"2004","unstructured":"Abramson DH, Schefler AC. Update on retinoblastoma. Retina. 2004;24:828\u201348.","journal-title":"Retina"},{"key":"772_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1055\/s-0032-1327563","volume":"224","author":"P Temming","year":"2012","unstructured":"Temming P, Lohmann D, Bornfeld N, Sauerwein W, Goericke SL, Eggert A. Current concepts for diagnosis and treatment of retinoblastoma in Germany: aiming for safe tumor control and vision preservation. Klin Padiatr. 2012;224:339\u201347.","journal-title":"Klin Padiatr"},{"key":"772_CR4","doi-asserted-by":"publisher","first-page":"532","DOI":"10.5301\/ejo.5000245","volume":"23","author":"D Huang","year":"2013","unstructured":"Huang D, Zhang Y, Zhang W, Wang Y, Zhang P, Hong L, Zhou Y, Han T, Zhi T. Study on clinical therapeutic effect including symptoms, eye preservation rate, and follow-up of 684 children with retinoblastoma. Eur J Ophthalmol. 2013;23:532\u20138.","journal-title":"Eur J Ophthalmol"},{"key":"772_CR5","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","volume":"379","author":"H Dimaras","year":"2012","unstructured":"Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, Gallie BL. Retinoblastoma. Lancet. 2012;379:1436\u201346.","journal-title":"Lancet"},{"key":"772_CR6","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.ophtha.2006.03.039","volume":"113","author":"K G\u00fcnd\u00fcz","year":"2006","unstructured":"G\u00fcnd\u00fcz K, M\u00fcft\u00fcoglu O, G\u00fcnalp I, Unal E, Ta\u00e7yildiz N. Metastatic retinoblastoma clinical features, treatment, and prognosis. Ophthalmology. 2006;113:1558\u201366.","journal-title":"Ophthalmology"},{"key":"772_CR7","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1001\/jamaophthalmol.2013.260","volume":"131","author":"GL Chantada","year":"2013","unstructured":"Chantada GL, Sampor C, Bosaleh A, Solernou V, Fandi\u00f1o A, de D\u00e1vila MT. Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients. JAMA Ophthalmol. 2013;131:1127\u201334.","journal-title":"JAMA Ophthalmol"},{"key":"772_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","volume":"13","author":"A Trotti","year":"2003","unstructured":"Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13:176\u201381.","journal-title":"Semin Radiat Oncol"},{"key":"772_CR9","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1001\/archophthalmol.2011.289","volume":"129","author":"S Kaliki","year":"2011","unstructured":"Kaliki S, Shields CL, Shah SU, Eagle RC, Shields JA, Leahey A. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Arch Ophthalmol. 2011;129:1422\u20137.","journal-title":"Arch Ophthalmol"},{"key":"772_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3928\/01913913-20121211-01","volume":"50","author":"FP Lim","year":"2013","unstructured":"Lim FP, Soh SY, Iyer JV, Tan AM, Swati H, Quah BL. Clinical profile, management, and outcome of retinoblastoma in Singapore. J Pediatr Ophthalmol Strabismus. 2013;50:106\u201312.","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"772_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1136\/bjo.87.3.330","volume":"87","author":"AO Schueler","year":"2003","unstructured":"Schueler AO, Hosten N, Bechrakis NE, Lemke AJ, Foerster P, Felix R, Foerster MH, Bornfeld N. High resolution magnetic resonance imaging of retinoblastoma. Br J Ophthalmol. 2003;87:330\u20135.","journal-title":"Br J Ophthalmol"},{"key":"772_CR12","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.33588\/rn.3112.2000091","volume":"31","author":"JJ Baiges-Octavio","year":"2000","unstructured":"Baiges-Octavio JJ, Huerta-Villanueva M. Meningeal carcinomatosis. Rev Neurol. 2000;31:1237\u201341.","journal-title":"Rev Neurol"},{"key":"772_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/INF.0b013e31818a896d","volume":"28","author":"KV Ota","year":"2009","unstructured":"Ota KV, Dimaras H, H\u00e9on E, Babyn PS, Yau YC, Read S, Budning A, Gallie BL, Chan HS. Toxocariasis mimicking liver, lung, and spinal cord metastases from retinoblastoma. Pediatr Infect Dis J. 2009;28:252\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"772_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/bjo.74.7.427","volume":"74","author":"BS Shine","year":"1990","unstructured":"Shine BS, Hungerford J, Vaghela B, Sheraidah GA. Electrophoretic assessment of aqueous and serum neurone-specific enolase in retinoblastoma and ocular malignant melanoma. Br J Ophthalmol. 1990;74:427\u201330.","journal-title":"Br J Ophthalmol"},{"key":"772_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/0002-9394(86)90471-X","volume":"101","author":"T Nakajima","year":"1986","unstructured":"Nakajima T, Kato K, Kaneko A, Tsumuraya M, Morinaga S, Shimosato Y. High concentrations of enolase, alpha- and gamma-subunits, in the aqueous humor in cases of retinoblastoma. Am J Ophthalmol. 1986;101:102\u20136.","journal-title":"Am J Ophthalmol"},{"key":"772_CR16","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/cncr.11952","volume":"100","author":"G Chantada","year":"2004","unstructured":"Chantada G, Fandi\u00f1o A, D\u00e1vila MT, Manzitti J, Raslawski E, Casak S, Schvartzman E. Results of a prospective study for the treatment of retinoblastoma. Cancer. 2004;100:834\u201342.","journal-title":"Cancer"},{"key":"772_CR17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/pbc.22504","volume":"55","author":"IJ Dunkel","year":"2010","unstructured":"Dunkel IJ, Khakoo Y, Kernan NA, Gershon T, Gilheeney S, Lyden DC, Wolden SL, Orjuela M, Gardner SL, Abramson DH. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. Pediatr Blood Cancer. 2010;55:55\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"772_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00277-008-0645-y","volume":"88","author":"YL Kwong","year":"2009","unstructured":"Kwong YL, Yeung DY, Chan JC. Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities. Ann Hematol. 2009;88:193\u2013201.","journal-title":"Ann Hematol"},{"key":"772_CR19","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1200\/JCO.1995.13.4.902","volume":"13","author":"F Doz","year":"1995","unstructured":"Doz F, Neuenschwander S, Plantaz D, Courbon B, Gentet JC, Bouffet E, Mosseri V, Vannier JP, Mechinaud F, Desjardins L. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Soci\u00e9t\u00e9 Fran\u00e7aise d'Oncologie P\u00e9diatrique. J Clin Oncol. 1995;13:902\u20139.","journal-title":"J Clin Oncol"},{"key":"772_CR20","first-page":"998","volume":"49","author":"S Bhasker","year":"2008","unstructured":"Bhasker S, Bajpai V, Turaka A. Palliative radiotherapy in paediatric malignancies. Singap Med J. 2008;49:998\u20131001.","journal-title":"Singap Med J"},{"key":"772_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/bmt.2011.108","volume":"47","author":"J Palma","year":"2012","unstructured":"Palma J, Sasso DF, Dufort G, Koop K, Sampor C, Diez B, Richard L, Castillo L, Chantada GL. Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America. Bone Marrow Transplant. 2012;47:522\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"772_CR22","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1136\/bjo.2008.148932","volume":"93","author":"R Cozza","year":"2009","unstructured":"Cozza R, De Ioris MA, Ilari I, Devito R, Fidani P, De Sio L, Demelas F, Romanzo A, Donfrancesco A. Metastatic retinoblastoma: single institution experience over two decades. Br J Ophthalmol. 2009;93:1163\u20136.","journal-title":"Br J Ophthalmol"},{"key":"772_CR23","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/MPH.0b013e31819c5275","volume":"31","author":"CO Bekibele","year":"2009","unstructured":"Bekibele CO, Ayede AI, Asaolu OO, Brown BJ. Retinoblastoma: the challenges of management in Ibadan, Nigeria. J Pediatr Hematol Oncol. 2009;31:552\u20135.","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0772-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-018-0772-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-018-0772-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T17:32:28Z","timestamp":1751563948000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-018-0772-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1186\/s12886-018-0772-8","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"12 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Medical Ethics Committee of the Beijing Tongren Hospital, and informed consent was waived due to the retrospective nature of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"107"}}